BOSULIF vs SORAFENIB TOSYLATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. BOSULIF and SORAFENIB TOSYLATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BOSULIF	SORAFENIB TOSYLATE
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BOSUTINIB MONOHYDRATE	SORAFENIB TOSYLATE
Manufacturer	Pf Prism Cv	Yabao Pharm
Dosage forms	Capsule, Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Bcr-Abl Positive Chronic Myelogenous Leukemia	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

bosulif sorafenib tosylate

Rating

New

Pharmacy pays

—

Type

Active ingredient

BOSUTINIB MONOHYDRATE

SORAFENIB TOSYLATE

Manufacturer

Pf Prism Cv

Yabao Pharm

Dosage forms

Capsule, Tablet

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Bcr-Abl Positive Chronic Myelogenous Leukemia

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Frequently asked questions

What is the difference between Bosulif and Sorafenib Tosylate?

Bosulif contains Bosutinib Monohydrate, while Sorafenib Tosylate contains Sorafenib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.